74 results
Page 2 of 4
8-K
EX-10.1
jsqjp2i4ez2rtp
3 Jun 20
Departure of Directors or Certain Officers
7:17am
8-K
EX-10.1
1f1qqy7s af
2 Dec 19
Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy
7:52am
8-K
EX-10.2
70rtf9m0ig5f4pc02v
2 Dec 19
Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy
7:52am
8-K
EX-10.1
0wawzqj5
10 Sep 19
Other Events
4:51pm
8-K
EX-10.7
gc4oohdwhywrecr5xb
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.5
76j2v
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.2
hrufh1393c9t
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.4
bxcyt pla3
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.6
mj8f8n
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
l514rd ct
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.3
jryugi1
25 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
zqj1fv zv
11 Sep 18
Xenon Enters into Agreement to Buy Out Milestones and Royalties Related to its XEN1101 Program
12:00am
8-K
EX-10.1
cznl8w6u7gaa ftau
7 Aug 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
9aaumro2hg
13 Jun 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
yku7wkj5q6ga00nb0v26
28 Mar 18
Entry into a Material Definitive Agreement
12:00am